Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Thrombocytopenia,Unspecified”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Testing effectiveness (Phase 2)Looking for participantsNCT06799611
What this trial is testing

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)Treatment
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT05279872
What this trial is testing

Zanubrutinib in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaBruton Tyrosine Kinase
Peking University People's Hospital 20
Not applicableNot Yet RecruitingNCT07014904
What this trial is testing

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915
What this trial is testing

Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Very early researchStudy completedNCT05551624
What this trial is testing

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Who this might be right for
Primary Immune Thrombocytopenia
Hospital Civil de Guadalajara 15
Not applicableUnknownNCT03429660
What this trial is testing

French Adult Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia
University Hospital, Toulouse 10,000
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Not applicableUnknownNCT05371743
What this trial is testing

Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Sohag University 2
Not applicableStudy completedNCT02063763
What this trial is testing

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

Who this might be right for
Adult PatientsImmune Primary ThrombocytopeniaSplenectomy+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 31
Testing effectiveness (Phase 2)Looking for participantsNCT07065968
What this trial is testing

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739
What this trial is testing

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Not applicableUnknownNCT05116423
What this trial is testing

Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)Study completedNCT04687072
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 207
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05653219
What this trial is testing

Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 152
Load More Results